Skip to main content

Instructions

Student presentations must have a faculty sponsor.

Abstracts must include a title and a description of the research, scholarship, or creative work. The description should be 150-225 words in length and constructed in a format or style appropriate for the presenter’s discipline.

The following points should be addressed within the selected format or style for the abstract:

  • A clear statement of the problem or question you pursued, or the scholarly goal or creative theme achieved in your work.
  • A brief comment about the significance or uniqueness of the work.
  • A clear description of the methods used to achieve the purpose or goals for the work.
  • A statement of the conclusions, results, outcomes, or recommendations, or if the work is still in progress, the results you expect to report at the event.

Presenter photographs should be head and shoulder shots comparable to passport photos.

Additional Information

More information is available at carthage.edu/celebration-scholars/. The following are members of the Research, Scholarship, and Creativity Committee who are eager to listen to ideas and answer questions:

  • Jun Wang
  • Kim Instenes
  • John Kirk
  • Nora Nickels
  • Andrew Pustina
  • James Ripley

The Superiority of Combination Psychopharmacotherapy over Monotherapy in Treating Depressive Disorders in Adolescents

Name: Brian Konieczny
Major: Psychology and Neuroscience
Hometown: Schaumburg, IL
Faculty Sponsor:
Other Sponsors:  
Type of research: Senior thesis

Abstract

Depressive disorders are highly prevalent in adolescents, and there are multiple possible causes as well as treatment methods for them. The literature currently appears to support an interaction between a mutated gene for serotonin transporters and environmental stressors that causes depression in adolescents. Two main treatment options are available for adolescents: psychotherapies and pharmacotherapy.  There are many different types of psychotherapies that can treat depression, but the two most prominent therapies are cognitive-behavioral therapy and interpersonal therapy.  Cognitive-behavioral therapy works to change faulty cognitions, and interpersonal psychotherapy works to improve interpersonal skills; both must be modified between adolescent and adult usage. Pharmacotherapy consists of drugs that target the serotonin transporter system, called selective serotonin reuptake inhibitors.  While controversy exists about the possible unknown impacts on brain development, two SSRIs have been cleared by the FDA as safe for treatment of depression in adolescents and adults.  Each treatment is effective, but a review of the literature over the past 15 years supports the claim that combination therapy of both psychotherapy and pharmacotherapy has been shown to be superior to either monotherapy.  Therefore, combination therapy is recommended for the treatment of depressive disorders in most adolescents.

Poster file

$(function() { $('#print h2').prepend('Print'); $('#print h2 a').click(function() { window.print(); return false; }); });